XENE R&D to Revenue
Xenon Pharmaceuticals Inc · R&D to Revenue
XENE R&D to Revenue
Latest reported0.00%period ending
XENE Quarterly R&D/Revenue (93.23% → 0.00%)
Latest values, visible window
High-resolution chart · PNG
XENE r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 816% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 22,296.2121% | |
| 4,131.7164% | |
| 220.8533% | |
| 585.6837% | |
| 232.5332% | |
| 828.5392% | |
| 374.2084% | |
| 290.6214% | |
| 199.0388% | |
| 80.0956% | |
| 166.5866% | |
| 353.0189% | |
| 278.6% | |
| 0% | |
| 0% | |
| 106.7667% | |
| 0% | |
| 0% | |
| 0% | |
| 39,981.25% | |
| 2,713.6364% | |
| 40,726.6667% | |
| 36,893.75% | |
| 1,169.1489% | |
| 1,444.3099% | |
| 1,235.5932% | |
| 726.1231% | |
| 132.1041% | |
| 88.3326% | |
| 90.6822% | |
| 85.4613% | |
| 70.7872% | |
| 24.3766% | |
| 48.4334% | |
| 50.6499% | |
| 49.1313% | |
| 23.8877% | |
| 63.5685% | |
| 63.5685% | |
| 93.2273% | |
| 93.2273% |